
The EMIS Network. EMIS-2017 – The European Men-Who-Have-Sex-With-Men Internet Survey. Key findings from 50 countries.
Report details:
Stockholm, European Centre for Disease Prevention and Control, 2019 (ISBN 978-92-9498-341-1).
Report details:
Stockholm, European Centre for Disease Prevention and Control, 2019 (ISBN 978-92-9498-341-1).
Since data collection has closed, we have distributed 39 country of residence datasets to our EMIS-2017 partners who are working on a wide range of national reports, in a variety of formats. As these reports are published they will be added here. No datasets were requested from Luxemburg, Bosnia iH, Iceland, or Turkey. As of June 2021, 20 countries have provided at least one national report. Many countries were interrupted in their report writing by the COVID-19 pandemic. We still expect a report from the Netherlands, Poland, Portugal, and Slovakia. No feedback has been received from BG, HR, LV/LT, SI, PH, RS. No reports are expected from Finland, Hungary, Lebanon, North Macedonia, Romania, or the United Kingdom.
EMIS-2017: Austria EMIS-2017 National Reports
EMIS-2017: Belarus EMIS-2017 National Reports
EMIS-2017: Belgium (België) EMIS-2017 National Reports
EMIS-2017: Belgium (Belgique) EMIS-2017 National Reports
EMIS-2017: Canada (main report) EMIS-2017 National Reports
EMIS-2017: Canada (Infographic summary) EMIS-2017 National Reports
EMIS-2017: Czechia EMIS-2017 National Reports
EMIS-2017: Cyprus EMIS-2017 National Reports
EMIS-2017: Denmark EMIS-2017 National Reports
EMIS-2017: Estonia EMIS-2017 National Reports
EMIS-2017: France EMIS-2017 National Reports
EMIS-2017: Germany EMIS-2017 National Reports
EMIS-2017: Greece (1) EMIS-2017 National Reports
EMIS-2017: Greece (2) EMIS-2017 National Reports
EMIS-2017: Ireland (Main Report) EMIS-2017 National Reports
EMIS-2017: Ireland (Community Report 1) EMIS-2017 National Reports
EMIS-2017: Ireland (Community Report 2) EMIS-2017 National Reports
EMIS-2017: Ireland (Community Report 3) EMIS-2017 National Reports
EMIS-2017: Ireland (Community Report 4) EMIS-2017 National Reports
EMIS-2017: Ireland (Infographic Demographics) EMIS-2017 National Reports
EMIS-2017: Ireland (Infographic Health) EMIS-2017 National Reports
EMIS-2017: Ireland (Infographic Behaviours) EMIS-2017 National Reports
EMIS-2017: Ireland (Infographic Needs) EMIS-2017 National Reports
EMIS-2017: Ireland (Infographic Interventions) EMIS-2017 National Reports
EMIS-2017: Ireland (Health technology assessment for PrEP) EMIS-2017 National Reports
EMIS-2017: Israel EMIS-2017 National Reports
EMIS-2017: Italy EMIS-2017 National Reports
EMIS-2017: Malta EMIS-2017 National Reports
EMIS-2017: Moldova EMIS-2017 National Reports
EMIS-2017: Norway EMIS-2017 National Reports
EMIS-2017: Russia EMIS-2017 National Reports
EMIS-2017: Spain EMIS-2017 National Reports
EMIS-2017: Sweden EMIS-2017 National Reports
EMIS-2017: Switzerland (Suisse) EMIS-2017 National Reports
For World AIDS Days 2018–2021 we partnered with UNAIDS to present some key findings from the European and Latin American MSM Internet Surveys on the UNAIDS website for key populations. Findings are shown as interactive maps that include various sexual health indicatiors for gay men, bisexual men and other MSM.
Suggested citation for EMIS/LAMIS indicators on the UNAIDS website for key populations:
UNAIDS Key Population Atlas: EMIS & LAMIS Indicators for men-who-have-sex-with-men. Geneva, 2018–21. Available at: https://kpatlas.unaids.org/dashboard
Disclaimer: Indicators published on the UNAIDS website for key populations based on data collected by the Latin America MSM Internet Survey (LAMIS) are not official/governmental data of the participating countries.
Available in 33 languages, the European MSM Internet Survey (EMIS-2017) recruited 137,358 qualifying participants from 46 countries across Europe and Lebanon, Israel, Canada and the Philippines. The Latin American MSM Internet Survey (LAMIS) recruited 64,655 participants from 18 countries.
EMIS-2017 was undertaken by researchers from Sigma Research at the London School for Hygiene and Tropical Medicine and the Robert Koch Institute. Data was collected between 18 October 2017 and 31 January 2018.
LAMIS, using the same questionnaire and finishing data collection on 12 May 2018, was the first multi-country survey for gay, bisexual, and other men who have sex with men (MSM) in Latin America. It was implemented by researchers from the RIGHT-PLUS*, a coalition of researchers from Latin America, Portugal, Spain and the Netherlands, with support from the EMIS team. EMIS and LAMIS required a great deal of international cooperation and relied on the support of national stakeholders to aid local recruitment. Through this cooperation comparable data are now available for the first time for more than 60 countries across 4 continents.
LAMIS contributions: CEEISCAT, Spain (Jordi Casabona Barbara, Percy Fernández Dávila): LAMIS network and local recruitment coordination, economic and legal aspects of hosting the database. CIISSS, Peru (Carlos F. Cáceres, E. Michael Reyes): LAMIS Report for Latin America. NUDHES, Brazil (Maria Amelia de Sousa Mascena Veras, Daniel Barros): study website and its graphic design. LSHTM, United Kingdom (Sigma Research: Axel J. Schmidt, Ford Hickson, David Reid, Peter Weatherburn): questionnaire design, support with survey software and monitoring of recruitment, graphic arts of banners for promotion, data cleaning and labelling, error handling, variable manual, templates for national and community reports, collaboration with UNAIDS. Robert Koch Institute, Germany (Ulrich Marcus): negotiations with web pages/apps for free promotion of LAMIS and coordination of central recruitment.
LAMIS acknowledgements: We thank all men who took part in LAMIS, as well as our app partners Grindr and PlanetRomeo who helped to recruit participants through free-of-charge instant messages, and our local partners who recruited participants via Facebook and other social media, and placed promotional banners on their websites. Thank you for being part of something huge!
The following list acknowledges all LAMIS partners by country.
AR: Federación Argentina de Lesbianas, Gays, Bisexuales y Trans (FALGBT). BO: Fundación Diversencia; MANODIVERSA. BR: Núcleo de Pesquisa em Direitos Humanos e Saúde LGBT+ (NUDHES) da Faculdade de Ciências Médicas da Santa Casa de São Paulo; ABGLT. CL: Escuela de Salud Pública – Universidad de Chile; Fundación Savia; APROFA. CO: Asociación Ágora; UNIMINUTO Seccional Bello. CR: Centro de Investigación y Promoción para América Central de Derechos Humanos (CIPAC). EC: Fundación Ecuatoriana Equidad. GT: Fundación Sida y Sociedad; Centro de Investigaciones de las Ciencias de la Salud, Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala. HN: Asociación Kukulcan. MX: Red GayLatino. NI: Centro para la Educación y Prevención del SIDA (CEPRESI). PA: Grupo Génesis Panamá+. PY: SOMOSGAY. PE: Center for Research on Sexuality, AIDS and Society at Universidad Peruana Cayetano Heredia. SR: Parea Surinam. SV: Asociación Entre Amigos. UY: Colectivo Ovejas Negras; +VIHdas. VE: Venezuela Igualitaria.
LAMIS funding: Questionnaire design, core survey execution and variable manual were provided by EMIS-2017 (funded by the EU Health Programme 2014–2020 for Europe), and adapted for LAMIS use. Additional financial support was provided by CEEISCAT, CIISSS, Instituto de Saúde Pública da Universidade do Porto, Maastricht University, NUDHES, and Robert Koch Institute.
*The Red Iberoamericana de Estudios en Hombres Gay, otros Hombres que tienen Sexo con Hombres y Personas Trans is composed of the following institutions: Núcleo de Pesquisa em Direitos Humanos e Saúde LGBT+ (NUDHES) da Faculdade de Ciências Médicas da Santa Casa de São Paulo (Brazil); Escuela de Salud Pública, Universidad de Chile (Chile); CIISSS at Universidad Peruana Cayetano Heredia (Peru); CICS – Facultad de Ciencias Médicas, Universidad de San Carlos de Guatemala (Guatemala); Instituto de Saúde Pública da Universidade do Porto (Portugal); the Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i VIH/Sida de Catalunya (CEEISCAT, Spain).
PLoS ONE, 2021; 16(3): e0248582 (doi: 10.1371/journal.pone.0248582).
Authors: Ulrich Marcus, Massimo Mirandola, Susanne B Schink, Lorenzo Gios, Axel J Schmidt
Background/Objectives: Many European countries reported increased numbers of syphilis, gonorrhoea and chlamydia diagnoses among men who have sex with men (MSM) in recent years. Behaviour changes and increased testing are thought to drive these increases.
Methods: In 2010 and 2017, two large online surveys for MSM in Europe (EMIS-2010, EMIS-2017) collected self-reported data on STI diagnoses in the previous 12 months, diagnostic procedures, STI symptoms when testing, number of sexual partners, and sexual behaviours such as condom use during the last intercourse with a non-steady partner in 46 European countries. Multivariate regression models were used to analyse factors associated with diagnoses of syphilis, gonorrhoea/chlamydia, and respective diagnoses classified as symptomatic and asymptomatic. If applicable, they included country-level screening rates.
Results: Questions on STI diagnoses and sexual behaviours were answered by 156,018 (2010) and 125,837 (2017) participants. Between 2010 and 2017, overall diagnoses with gonorrhoea/chlamydia and syphilis increased by 76% and 83% across countries. Increases were more pronounced for asymptomatic compared to symptomatic infections. The proportion of respondents screened and the frequency of screening grew considerably. Condomless anal intercourse with the last non-steady partner rose by 62%; self-reported partner numbers grew. Increased syphilis diagnoses were largely explained by behavioural changes (including more frequent screening). Gonorrhoea/chlamydia increases were mainly explained by more screening and a change in testing performance. A country variable representing the proportion of men screened for asymptomatic infection was positively associated with reporting symptomatic gonorrhoea/chlamydia, but not syphilis.
Discussion/Conclusion: The positive association of country-level screening rates with the proportion of symptomatic infections with gonorrhoea/chlamydia may indicate a paradoxical effect of screening on incidence of symptomatic infections. Treatment of asymptomatic men might render them more susceptible to new infections, while spontaneous clearance may result in reduced susceptibility. Before expanding screening programmes, evidence of the effects of screening and treatment is warranted.
PLoS ONE, 2021; 16(3): e0248582 (doi: 10.1371/journal.pone.0248582).
Authors: Ulrich Marcus, Massimo Mirandola, Susanne B Schink, Lorenzo Gios, Axel J Schmidt
Background/Objectives: Many European countries reported increased numbers of syphilis, gonorrhoea and chlamydia diagnoses among men who have sex with men (MSM) in recent years. Behaviour changes and increased testing are thought to drive these increases.
Methods: In 2010 and 2017, two large online surveys for MSM in Europe (EMIS-2010, EMIS-2017) collected self-reported data on STI diagnoses in the previous 12 months, diagnostic procedures, STI symptoms when testing, number of sexual partners, and sexual behaviours such as condom use during the last intercourse with a non-steady partner in 46 European countries. Multivariate regression models were used to analyse factors associated with diagnoses of syphilis, gonorrhoea/chlamydia, and respective diagnoses classified as symptomatic and asymptomatic. If applicable, they included country-level screening rates.
Results: Questions on STI diagnoses and sexual behaviours were answered by 156,018 (2010) and 125,837 (2017) participants. Between 2010 and 2017, overall diagnoses with gonorrhoea/chlamydia and syphilis increased by 76% and 83% across countries. Increases were more pronounced for asymptomatic compared to symptomatic infections. The proportion of respondents screened and the frequency of screening grew considerably. Condomless anal intercourse with the last non-steady partner rose by 62%; self-reported partner numbers grew. Increased syphilis diagnoses were largely explained by behavioural changes (including more frequent screening). Gonorrhoea/chlamydia increases were mainly explained by more screening and a change in testing performance. A country variable representing the proportion of men screened for asymptomatic infection was positively associated with reporting symptomatic gonorrhoea/chlamydia, but not syphilis.
Discussion/Conclusion: The positive association of country-level screening rates with the proportion of symptomatic infections with gonorrhoea/chlamydia may indicate a paradoxical effect of screening on incidence of symptomatic infections. Treatment of asymptomatic men might render them more susceptible to new infections, while spontaneous clearance may result in reduced susceptibility. Before expanding screening programmes, evidence of the effects of screening and treatment is warranted.